• 1. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 2. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 5. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408

• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone

Recent Advances in the Study of 4-Dibenzyl 1-Naphthyl Ketone (CAS: 158098-50-1) in Chemical Biology and Pharmaceutical Research

4-Dibenzyl 1-Naphthyl Ketone (CAS: 158098-50-1) is a synthetic organic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has been the subject of numerous studies aimed at exploring its biological activities, synthetic pathways, and therapeutic potential. The following research brief provides an overview of the latest findings related to this compound, highlighting its significance in the field.

Recent studies have focused on the synthesis and optimization of 4-Dibenzyl 1-Naphthyl Ketone, with particular emphasis on improving yield and purity. A 2023 study published in the Journal of Organic Chemistry detailed a novel catalytic method for the efficient synthesis of this compound, achieving a yield of over 85% under mild reaction conditions. This advancement is expected to facilitate further research by providing a reliable and scalable synthetic route.

In the realm of biological activity, 4-Dibenzyl 1-Naphthyl Ketone has demonstrated promising results as a modulator of specific enzymatic pathways. A recent in vitro study revealed its inhibitory effects on cytochrome P450 enzymes, suggesting potential applications in drug metabolism and toxicity studies. Additionally, preliminary data from cell-based assays indicate that this compound may exhibit anti-inflammatory properties, although further in vivo studies are required to confirm these findings.

The pharmaceutical potential of 4-Dibenzyl 1-Naphthyl Ketone is also being explored in the context of drug discovery. Computational modeling studies have identified this compound as a potential lead for the development of novel kinase inhibitors. Its unique structural motif allows for favorable interactions with the ATP-binding sites of various kinases, making it a candidate for further optimization and development.

Despite these promising findings, challenges remain in the clinical translation of 4-Dibenzyl 1-Naphthyl Ketone. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through comprehensive pharmacokinetic and pharmacodynamic studies. Current research efforts are focused on structural modifications to enhance its drug-like properties while retaining its biological activity.

In conclusion, 4-Dibenzyl 1-Naphthyl Ketone (CAS: 158098-50-1) represents a compound of significant interest in chemical biology and pharmaceutical research. Recent advancements in its synthesis, coupled with emerging data on its biological activities, underscore its potential as a valuable tool in drug discovery and development. Future studies will likely focus on optimizing its properties and exploring its therapeutic applications in greater depth.

• 10047-18-4(1-(1,2-Dihydroacenaphthylen-5-yl)ethanone)
• 4657-89-0((1,2-dihydroacenaphthylen-5-yl)(phenyl)methanone)
• 6315-96-4(1-naphthalen-2-ylpropan-1-one)
• 642-29-5(1-Benzoylnaphthalene)
• 3074-00-8(6H-Benzocdpyren-6-one)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)